p.(Asp47Asn) and p.(Thr62Met): non deleterious LDL receptor missense variants functionally characterized in vitro
Open Access
- 9 November 2018
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 16614
Abstract
Familial Hypercholesterolemia (FH) is a common genetic disorder caused most often by mutations in the Low Density Lipoprotein Receptor gene (LDLr) leading to high blood cholesterol levels, and ultimately to development of premature coronary heart disease. Genetic analysis and subsequent cascade screening in relatives allow diagnosis of FH at early stage, especially relevant to diagnose children. So far, more than 2300 LDLr variants have been described but only a minority of them have been functionally analysed to evaluate their pathogenicity in FH. Thus, identifying pathogenic mutations in LDLr is a long-standing challenge in the field. In this study, we investigated in vitro the activity p.(Asp47Asn) and p.(Thr62Met) LDLr variants, both in the LR1 region. We used CHO-ldlA7 transfected cells with plasmids carrying p.(Asp47Asn) or p.(Thr62Met) LDLr variants to analyse LDLr expression by FACS and immunoblotting, LDL binding and uptake was determined by FACS and analysis of mutation effects was assessed in silico. The in vitro activity assessment of p.(Asp47Asn) and p.(Thr62Met) LDLr variants shows a fully functional LDL binding and uptake activities. Therefore indicating that the three of them are non-pathogenic LDLr variants. These findings also emphasize the importance of in vitro functional LDLr activity studies to optimize the genetic diagnosis of FH avoiding the report of non-pathogenic variants and possible misdiagnose in relatives if cascade screening is carried out.Keywords
This publication has 28 references indexed in Scilit:
- The Type of LDLR Gene Mutation Predicts Cardiovascular Risk in Children with Familial HypercholesterolemiaThe Journal of Pediatrics, 2009
- Update of Japanese common LDLR gene mutations and their phenotypes: Mild type mutation L547V might predominate in the Japanese populationAtherosclerosis, 2009
- Update of the molecular basis of familial hypercholesterolemia in The NetherlandsHuman Mutation, 2005
- LOVD: Easy creation of a locus-specific sequence variation database using an “LSDB-in-a-box” approachHuman Mutation, 2005
- The important role for βVLDLs binding at the fourth cysteine of first ligand-binding domain in the low-density lipoprotein receptorJournal of Human Genetics, 2004
- Comparison of SSCP and DHPLC for the detection of LDLR mutations in a New Zealand cohortHuman Mutation, 2002
- A molecular genetic service for diagnosing individuals with familial hypercholesterolaemia (FH) in the United KingdomEuropean Journal of Human Genetics, 2001
- Folding, Calcium Binding, and Structural Characterization of a Concatemer of the First and Second Ligand-Binding Modules of the Low-Density Lipoprotein ReceptorBiochemistry, 1998
- A Deletion in the First Cysteine‐Rich Repeat of the Low‐Density‐Lipoprotein Receptor Leads to the Formation of Multiple Misfolded IsomersEuropean Journal of Biochemistry, 1996
- Disulfide bridges of a cysteine-rich repeat of the LDL receptor ligand-binding domainBiochemistry, 1995